Atomoxetine Dosing for a 17-Year-Old Male
For a 17-year-old male with ADHD, initiate atomoxetine at approximately 40 mg daily (0.5 mg/kg/day for most adolescents), then titrate after a minimum of 3 days to the target dose of 1.2 mg/kg/day, with a maximum of 100 mg/day, whichever is lower. 1
Initial Dosing Strategy
- Starting dose: Begin with approximately 40 mg once daily in the morning 1
- Titration timeline: After a minimum of 3 days, increase to the target dose of 1.2 mg/kg/day 1
- Maximum dose: Do not exceed 1.4 mg/kg/day or 100 mg/day, whichever is lower 1
Dosing Schedule Options
The daily dose can be administered in two ways to optimize tolerability: 1
- Once-daily dosing: Single morning dose provides "around-the-clock" symptom control 1
- Twice-daily dosing: Split into two equal doses (morning and evening) may reduce gastrointestinal side effects, particularly if titrated too rapidly 1
Important consideration: Slow titration with twice-daily dosing over at least 2 weeks significantly reduces early adverse events compared to rapid titration to 1.2 mg/kg/day over 3 days 2. Specifically, slower titration reduces somnolence (4.2% vs 14.3%) and decreased appetite (8.0% vs 14.3%) during the first 2 weeks 2.
Weight-Based Dosing Algorithm
For a typical 17-year-old male:
- If weight ≤70 kg: Target dose = 1.2 mg/kg/day (typically 60-80 mg/day) 1
- If weight >70 kg: Target dose approaches the 100 mg/day maximum 1
- If weight >83 kg: Maximum dose is capped at 100 mg/day regardless of weight 1
Expected Timeline for Therapeutic Effect
Critical counseling point: Unlike stimulants, atomoxetine requires 6-12 weeks to achieve full therapeutic effect 1. This delayed onset must be clearly communicated to the patient and family to prevent premature discontinuation.
Monitoring Requirements
Before initiating treatment, obtain: 3, 1
- Personal and family cardiac history (sudden death, cardiovascular symptoms, Wolff-Parkinson-White syndrome, hypertrophic cardiomyopathy, long QT syndrome) 3
- Baseline heart rate and blood pressure 3
- Consider ECG if any cardiac risk factors are present 3
During treatment, monitor closely for: 1
- Suicidality: Black box warning requires close monitoring for suicidal ideation, clinical worsening, and unusual behavioral changes, especially during the first few months and at dose changes 1
- Cardiovascular parameters: Heart rate and blood pressure (atomoxetine may increase both) 3, 1
- Growth parameters: Height and weight (atomoxetine may cause initial growth delays in first 1-2 years) 3
Common Adverse Effects
Most frequent side effects in adolescents include: 1
- Nausea, vomiting, and abdominal pain (often transient, reduced with slower titration) 1
- Decreased appetite 1
- Fatigue and somnolence 1
- Headache 1
Special Considerations for Adolescents
Atomoxetine may be particularly appropriate as first-line therapy in this age group if: 1
- Comorbid substance use disorder or risk of substance abuse (atomoxetine is not a controlled substance) 1
- Comorbid tic disorder or Tourette's syndrome 1
- Comorbid anxiety disorder 1
- Patient preference to avoid controlled substances 1
- Need for continuous 24-hour symptom control 1
However, recognize that atomoxetine has smaller effect sizes than stimulants and is generally recommended as second-line therapy when stimulants have failed or are contraindicated 1.
Drug Interactions
Critical interaction: Atomoxetine is metabolized via CYP2D6 1. Approximately 7% of the population are poor metabolizers with significantly higher plasma levels and longer half-lives, leading to increased adverse effects 1. Concomitant use of CYP2D6 inhibitors (e.g., fluoxetine, paroxetine) can elevate atomoxetine levels and may require dose adjustment 1.
Hepatic Impairment
If the patient has any hepatic impairment, dose adjustment is mandatory 4: